tradingkey.logo
搜尋

Psyence Biomedical Ltd

PBM
添加自選
3.190USD
-0.170-5.06%
收盤 07-31 16:00美東報價延遲15分鐘
36.38K總市值
虧損本益比TTM

關於 Psyence Biomedical Ltd 公司

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Psyence Biomedical Ltd簡介

公司代碼PBM
公司名稱Psyence Biomedical Ltd
上市日期Dec 10, 2021
CEOMaresky (Neil)
員工數量12
證券類型Ordinary Share
年結日Dec 10
公司地址121 Richmond Street West Penthouse
城市TORONTO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Canada
郵編M5H 2K1
電話17744604171
網址
公司代碼PBM
上市日期Dec 10, 2021
CEOMaresky (Neil)

Psyence Biomedical Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--

常見問題

Psyence Biomedical Ltd的前五大股東是誰?

Psyence Biomedical Ltd的前五大股東如下:Dr. Neil Maresky

有多少機構持有Psyence Biomedical Ltd(PBM)的股份?

截至2026Q1,共有24家機構持有Psyence Biomedical Ltd的股份,合計持有的股份價值約為159.81K,占公司總股份的6.96% 。與2025Q4相比,機構持股有所增加,增幅為112677.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有